Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -284 | -144 | N/A | -772 | -637 |
| Depreciation Amortization | 6 | 3 | N/A | 9 | 6 |
| Accounts receivable | N/A | N/A | N/A | 23 | 23 |
| Accounts payable and accrued liabilities | -120 | -109 | N/A | -86 | -72 |
| Other Working Capital | -87 | -101 | N/A | -15 | -15 |
| Other Operating Activity | 121 | 111 | 0 | 371 | 354 |
| Operating Cash Flow | $-363 | $-240 | $N/A | $-470 | $-341 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18 | -12 | N/A | 203 | 144 |
| Investing Cash Flow | $-18 | $-12 | $N/A | $203 | $144 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 500 | 500 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -49 | -29 |
| Financing Cash Flow | $500 | $500 | $N/A | $-49 | $-29 |
| Beginning Cash Position | 69 | 69 | N/A | 489 | 489 |
| End Cash Position | 187 | 317 | N/A | 173 | 262 |
| Net Cash Flow | $119 | $248 | $N/A | $-316 | $-227 |
| Free Cash Flow | |||||
| Operating Cash Flow | -363 | -240 | N/A | -470 | -341 |
| Free Cash Flow | -363 | -240 | 0 | -470 | -341 |